Why Neurocrine Biosciences, Epizyme, and Plug Power Are Today's 3 Best Stocks
The S&P 500 delivers its first gain of the year while Neurocrine Biosciences, Epizyme, and Plug Power all rocket higher by at least 39%!
Why Epizyme, Neurocrine Biosciences, and Peregrine Soared
These 3 biotechs could beat the broader market this year.
Why Neurocrine Biosciences Inc. Shares Skyrocketed
Neurocrine shows short-minded investors why bailing during dose-escalation studies wasn't the smartest idea.